WPD Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WPDPF research report →
About the company
WPD Pharmaceuticals Inc. , with its main office located in Vancouver, Canada, specializes in the discovery and development of pharmaceutical agents. The company's core mission is to advance innovative treatments for both various forms of cancer (oncology) and infectious diseases.
- CEO
- Mariusz Olejniczak
- IPO
- 2020
- Employees
- 16
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $140
- P/E
- -100.00
- P/S
- 0.00
- P/B
- -14.30
- EV/EBITDA
- -13.43
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 15.48%
- ROIC
- 106.68%
- Revenue
- $0 · 0.00%
- Net Income
- $-80,082 · -102.08%
- EPS
- $-0.00 · -102.06%
- Op Income
- $-268,910
- FCF YoY
- 94.08%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.14
- Avg Volume
- 4.40K
Get TickerSpark's AI analysis on WPDPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our WPDPF coverage
Recent articles, reports, and earnings notes.
No research on WPDPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WPDPF report →Similar companies
Peers in the same neighborhood.